Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by mercedesmanon Apr 10, 2023 9:48am
412 Views
Post# 35386463

I thought…

I thought…

I thought JK did an excellent job of explaining why enrolment will increase in clinical practice and once the SOC versus under the strict Trial criteria 

Which also helps to explain the underestimated EBITDA calculations and the true addressable market (300,000 to 400,000) or 2 to 3 times more than the number of patients assumed (140,000) in the EBITDA calculations. 

That plus the guided and comparable EBITDA multiples mentioned during the presentation , mean that a new SP valuation/ calculation will soon be in order  ! 

Also good to see that JK is committed to seeing this through and sees it the culmination of his life's work in Sepsis and hemoperfusion.

Excited to see what transpires in the next 12-24 months !!

Holding and strategically still accumulating based on explosive potential. 

MM


 

<< Previous
Bullboard Posts
Next >>